Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
CRG Partners III L.P. | 0001637591 | Jul-03-2023 | 10 percent owner |
CRG Partners III - Parallel Fund (A) L.P. | 0001651357 | Jul-03-2023 | 10 percent owner |
CR Group L.P. | 0001702352 | Jul-03-2023 | 10 percent owner |
CRG Partners III - Parallel Fund B (Cayman) L.P. | 0001767508 | Jul-03-2023 | 10 percent owner |
CRG Partners III (Cayman) Lev AIV I L.P. | 0001767509 | Jul-03-2023 | 10 percent owner |
CRG Partners III (Cayman) Unlev AIV I L.P. | 0001767510 | Jul-03-2023 | 10 percent owner |
Giffin Brett A. | 0001892921 | Nov-08-2021 | officer: Chief Commercial Officer |
Adams Laura Lee | 0001891764 | Oct-18-2021 | director |
Ahuja Aparna | 0001840844 | Jan-05-2021 | officer: Chief Medical Officer |
Bernard Thierry | 0001815490 | Jun-14-2020 | director |
Saunders Ninfa | 0001815499 | Jun-14-2020 | director |
Toft Robin | 0001815565 | Jun-14-2020 | director |
Pare Anthony | 0001418863 | Jan-13-2020 | officer: Chief Commercial Officer |
Sperzel John J III | 0001602618 | Jan-08-2020 | director, officer: See Remarks |
CUMMING JOHN W | 0001181189 | Jun-02-2018 | director |
Cima Michael J. | 0001615992 | Jun-02-2018 | director |
Lapidus Stanley | 0001678195 | Jun-02-2018 | director |
Barclay Alec | 0001734339 | Mar-06-2018 | officer: SVP, Operations |
Lowery Thomas J. | 0001615632 | Mar-01-2018 | officer: Chief Scientific Officer |
McDonough John | 0001615937 | Mar-01-2018 | director, officer: President and CEO |
Gibbs Michael Terrence | 0001665000 | Mar-01-2018 | officer: General Counsel |
Sprague John M | 0001730056 | Jan-30-2018 | officer: Chief Financial Officer |
LIEBMAN SEYMOUR | 0001252287 | Jan-01-2018 | director |
Elsbree David B | 0001292650 | Nov-16-2017 | director |
DEPTULA-HICKS DARLENE M | 0001089409 | May-01-2017 | officer: Chief Financial Officer |
CANON INC | 0000016988 | Sep-21-2016 | 10 percent owner |
CANON U.S.A., INC. | 0001685215 | Sep-21-2016 | 10 percent owner |
Spadoro Joanne | 0001684042 | Sep-06-2016 | officer: Chief Operations Officer |
Lynch Shawn | 0001674756 | May-16-2016 | officer: Chief Financial Officer |
Jones Adrian M | 0001359316 | Mar-09-2016 | director |
Dhanda Rahul | 0001667658 | Feb-11-2016 | officer: SVP of Corporate Development |
SCHIFF ANDREW N | 0001172252 | Dec-09-2015 | 10 percent owner |
ELMS STEVE | 0001250195 | Dec-09-2015 | director, 10 percent owner |
Purcell Dennis J | 0001297291 | Dec-09-2015 | 10 percent owner |
AISLING CAPITAL III LP | 0001444717 | Dec-09-2015 | 10 percent owner |
Aisling Capital Partners III LP | 0001532634 | Dec-09-2015 | 10 percent owner |
Aisling Capital Partners III LLC | 0001532635 | Dec-09-2015 | 10 percent owner |
Harding David | 0001340147 | Oct-30-2015 | officer: Chief Commercial Officer |
CASTONGUAY MAURICE L | 0001205457 | Aug-05-2015 | officer: Chief Financial Officer |
GOLDMAN SACHS & CO | 0000769993 | Aug-12-2014 | 10 percent owner |
GOLDMAN SACHS GROUP INC | 0000886982 | Aug-12-2014 | 10 percent owner |
CARELLA THOMAS J. | 0001477767 | Aug-12-2014 | director |
Bridge Street 2013, L.P. | 0001572490 | Aug-12-2014 | 10 percent owner |
Bridge Street 2013 Offshore, L.P. | 0001572491 | Aug-12-2014 | 10 percent owner |
MBD 2013, L.P. | 0001572501 | Aug-12-2014 | 10 percent owner |
MBD 2013 Offshore, L.P. | 0001572502 | Aug-12-2014 | 10 percent owner |
Broad Street Principal Investments, L.L.C. | 0001575993 | Aug-12-2014 | 10 percent owner |
MBD Advisors, L.L.C. | 0001589295 | Aug-12-2014 | 10 percent owner |
Bridge Street Opportunity Advisors, L.L.C. | 0001615636 | Aug-12-2014 | 10 percent owner |
Bridge Street 2013 Holdings, L.P. | 0001615711 | Aug-12-2014 | 10 percent owner |
MBD 2013 Holdings, L.P. | 0001615732 | Aug-12-2014 | 10 percent owner |
WILCOX HARRY W | 0001079136 | Aug-06-2014 | director |
LAPIDUS STANLEY N | 0001166721 | Aug-06-2014 | director |
AFEYAN NOUBAR | 0001222012 | Aug-06-2014 | 10 percent owner |
KANIA EDWIN M JR | 0001255927 | Aug-06-2014 | 10 percent owner |
Crane Alan L | 0001294361 | Aug-06-2014 | director |
Flagship Ventures Fund 2004 L P | 0001299790 | Aug-06-2014 | 10 percent owner |
Flagship Ventures General Partner LLC | 0001400249 | Aug-06-2014 | 10 percent owner |
Polaris Venture Partners Special Founders' Fund V, L.P. | 0001439586 | Aug-06-2014 | 10 percent owner |
Polaris Venture Partners Entrepreneurs' Fund V, L.P. | 0001439587 | Aug-06-2014 | 10 percent owner |
Polaris Venture Partners Founders' Fund V, L.P. | 0001439588 | Aug-06-2014 | 10 percent owner |
Polaris Venture Management Co. V, L.L.C. | 0001439589 | Aug-06-2014 | 10 percent owner |
Polaris Venture Partners V, L.P. | 0001439590 | Aug-06-2014 | 10 percent owner |
Flagship Ventures Fund IV, L.P. | 0001503559 | Aug-06-2014 | 10 percent owner |
Flagship Ventures Fund IV General Partner LLC | 0001508051 | Aug-06-2014 | 10 percent owner |
Bilenker Joshua H. | 0001612312 | Aug-06-2014 | director |
Pfaller Michael A. | 0001615626 | Aug-06-2014 | officer: Chief Medical Officer |
Kalil Sarah O. | 0001615652 | Aug-06-2014 | officer: Chief Operating Officer |
Jones Marc R. | 0001615970 | Aug-06-2014 | officer: Chief Financial Officer |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by T2 Biosystems, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
S-1 | Document | General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001193125-24-105041 (33 Act) Size: 418 KB |
Apr-22-2024 | 24861997 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-24-102956 (34 Act) Size: 134 KB |
Apr-19-2024 | 24858233 |
8-K | Document | Current report filing Acc-no: 0001193125-24-100790 (34 Act) Size: 297 KB |
Apr-18-2024 | 24854424 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-010906 ( Act) Size: 22 KB |
Apr-16-2024 | |
8-K | Document | Current report filing Acc-no: 0001193125-24-094802 (34 Act) Size: 139 KB |
Apr-12-2024 | 24842086 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-24-039310 (34 Act) Size: 13290 KB |
Apr-01-2024 | 24809216 |
8-K | Document | Current report filing Acc-no: 0001193125-24-080700 (34 Act) Size: 157 KB |
Mar-28-2024 | 24799607 |
8-K | Document | Current report filing Acc-no: 0001193125-24-072143 (34 Act) Size: 206 KB |
Mar-20-2024 | 24766491 |
8-K | Document | Current report filing Acc-no: 0001193125-24-069715 (34 Act) Size: 166 KB |
Mar-18-2024 | 24757058 |
8-K | Document | Current report filing Acc-no: 0001193125-24-065471 (34 Act) Size: 137 KB |
Mar-12-2024 | 24740376 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000921895-24-000638 (34 Act) Size: 81 KB |
Mar-11-2024 | 24739532 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000921895-24-000637 (34 Act) Size: 81 KB |
Mar-11-2024 | 24739520 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0001193125-24-057912 (34 Act) Size: 476 KB |
Mar-04-2024 | 24715375 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-021248 ( Act) Size: 6 KB |
Feb-27-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-021243 ( Act) Size: 6 KB |
Feb-27-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-021242 ( Act) Size: 6 KB |
Feb-27-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-017073 ( Act) Size: 6 KB |
Feb-20-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-017070 ( Act) Size: 6 KB |
Feb-20-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-017071 ( Act) Size: 6 KB |
Feb-20-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-017069 ( Act) Size: 6 KB |
Feb-20-2024 |
Recent 20 filings. View all T2 Biosystems, Inc. filings
Very good communication and delivery made within the timeframe I was advised of
Thanks I look forward to using the product to improve my skin tone
It's being easier working on the website. And I recommend, it's a great website
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by